Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1990 Feb;65(2):175–177. doi: 10.1136/adc.65.2.175

Bacterial reservoirs in cystic fibrosis.

C J Taylor 1, J McGaw 1, R Howden 1, B I Duerden 1, P S Baxter 1
PMCID: PMC1792238  PMID: 2317061

Abstract

To establish whether colonisation of the upper respiratory tract or bacterial contamination of inhaler devices or solutions predisposes to colonisation of the lower respiratory tract in patients with cystic fibrosis, bacterial isolates from groups of children who were positive (n = 13) or negative (n = 18) for Pseudomonas aeruginosa were studied. Cultures of swabs from inhaler devices, toothbrushes, and upper airways were compared with cough swabs or sputum cultures. No pathogens were obtained from inhaler equipment administering unit dose medications. Upper airway carriage of Staphylococcus aureus and Haemophilus influenzae was identified in both groups but correlated poorly with sputum isolates. P. aeruginosa was found only in the upper respiratory tract of children with established colonisation of the lower airways. No P aeruginosa isolates were obtained from the upper airways of the group with negative sputum, including one patient who became colonised by P aeruginosa during the study. Our results did not support the suggestion that colonisation of the upper respiratory tract by P aeruginosa predisposes to colonisation of the lower airways. Failure to isolate pathogenic organisms consistently from the upper airways in patients with positive sputum argues against a local epithelial factor predisposing to bacterial colonisation.

Full text

PDF
175

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes K. L., Clifford R., Holgate S. T., Murphy D., Comber P., Bell E. Bacterial contamination of home nebuliser. Br Med J (Clin Res Ed) 1987 Oct 3;295(6602):812–812. doi: 10.1136/bmj.295.6602.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boucher R. C., Stutts M. J., Knowles M. R., Cantley L., Gatzy J. T. Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest. 1986 Nov;78(5):1245–1252. doi: 10.1172/JCI112708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Guggenbichler J. P., Allerberger F., Dierich M. P., Schmitzberger R., Semenitz E. Spaced administration of antibiotic combinations to eliminate pseudomonas from sputum in cystic fibrosis. Lancet. 1988 Sep 24;2(8613):749–750. doi: 10.1016/s0140-6736(88)90226-7. [DOI] [PubMed] [Google Scholar]
  4. Howden R. A new medium for the isolation of Staphylococcus aureus, including thymine requiring strains, from sputum. Med Lab Sci. 1981 Jan;38(1):29–33. [PubMed] [Google Scholar]
  5. Jones P. D., Moritz V., Pierce R. J. Microbial contamination of domiciliary nebuliser therapy equipment. Aust N Z J Med. 1985 Oct;15(5):585–589. [PubMed] [Google Scholar]
  6. Komiyama K., Tynan J. J., Habbick B. F., Duncan D. E., Liepert D. J. Pseudomonas aeruginosa in the oral cavity and sputum of patients with cystic fibrosis. Oral Surg Oral Med Oral Pathol. 1985 Jun;59(6):590–594. doi: 10.1016/0030-4220(85)90187-2. [DOI] [PubMed] [Google Scholar]
  7. Littlewood J. M., Miller M. G., Ghoneim A. T., Ramsden C. H. Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet. 1985 Apr 13;1(8433):865–865. doi: 10.1016/s0140-6736(85)92222-6. [DOI] [PubMed] [Google Scholar]
  8. Morris A. H. Nebulizer contamination in a burn unit. Am Rev Respir Dis. 1973 May;107(5):802–808. doi: 10.1164/arrd.1973.107.5.802. [DOI] [PubMed] [Google Scholar]
  9. REINARZ J. A., PIERCE A. K., MAYS B. B., SANFORD J. P. THE POTENTIAL ROLE OF INHALATION THERAPY EQUIPMENT IN NOSOCOMIAL PULMONARY INFECTION. J Clin Invest. 1965 May;44:831–839. doi: 10.1172/JCI105195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sanders C. V., Jr, Luby J. P., Johanson W. G., Jr, Barnett J. A., Sanford J. P. Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med. 1970 Jul;73(1):15–21. doi: 10.7326/0003-4819-73-1-15. [DOI] [PubMed] [Google Scholar]
  11. Turk D. C. The pathogenicity of Haemophilus influenzae. J Med Microbiol. 1984 Aug;18(1):1–16. doi: 10.1099/00222615-18-1-1. [DOI] [PubMed] [Google Scholar]
  12. Woods D. E., Bass J. A., Johanson W. G., Jr, Straus D. C. Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infect Immun. 1980 Dec;30(3):694–699. doi: 10.1128/iai.30.3.694-699.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. van Saene H. K., Stoutenbeek C. P. Selective decontamination. J Antimicrob Chemother. 1987 Oct;20(4):462–465. doi: 10.1093/jac/20.4.462. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES